Uncategorized

What works in COVID-19? Non-pharmaceutical interventions.

Gareth S Kantor In mid-February, reports from China1 suggested that the anti-malaria drug chloroquine might be an effective treatment for COVID-19 disease. A subsequent French clinical trial2 of the related drug hydroxychloroquine, which is used primarily to treat patients with the autoimmune disease lupus, has set off a global rush to stockpile both these drugs, fueled in part by Donald Trump’s comment that this is “a real chance to be one of the biggest game changers in the history of medicine”3. The chloroquine and hydroxychloroquine clinical trials were...

Outcomes measurement is “spurious”?

John Kane-Berman in Politicsweb (October 6, 2019) objects to Health Market Inquiry (HMI) recommendations that there be mandatory outcomes reporting in the private health sector, quoting an (un-named) general practitioner who says reporting outcomes is “spurious”. A second un-named health professional, a “specialist”, puts forward a number of specific objections: Specialists (i.e. roughly 50% of doctors), would be prejudiced, having the worst outcomes only because of the need to “rectify” everyone else’s “failed care” . A “rich demanding patient...